Conmed (CNMD) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.19% |
| Dec 31, 2025 | 10.67% |
| Sep 30, 2025 | 5.36% |
| Jun 30, 2025 | 6.64% |
| Mar 31, 2025 | 35.53% |
| Dec 31, 2024 | 16.01% |
| Sep 30, 2024 | 15.28% |
| Jun 30, 2024 | 17.54% |
| Mar 31, 2024 | 18.21% |
| Dec 31, 2023 | 18.50% |
| Sep 30, 2023 | 19.75% |
| Jun 30, 2023 | 19.37% |
| Mar 31, 2023 | 19.98% |
| Dec 31, 2022 | 21.66% |
| Sep 30, 2022 | 22.11% |
| Jun 30, 2022 | 20.49% |
| Mar 31, 2022 | 17.95% |
| Dec 31, 2021 | 18.10% |
| Sep 30, 2021 | 17.62% |
| Jun 30, 2021 | 15.42% |
| Mar 31, 2021 | 6.36% |
| Dec 31, 2020 | 8.99% |
| Sep 30, 2020 | 14.66% |
| Jun 30, 2020 | 13.08% |
| Mar 31, 2020 | 10.31% |
| Dec 31, 2019 | 12.71% |
| Sep 30, 2019 | -10.28% |
| Jun 30, 2019 | 18.45% |
| Mar 31, 2019 | 17.93% |
| Dec 31, 2018 | 11.20% |
| Sep 30, 2018 | 9.36% |
| Jun 30, 2018 | 14.54% |
| Mar 31, 2018 | 14.86% |
| Dec 31, 2017 | 7.03% |
| Sep 30, 2017 | 6.58% |
| Jun 30, 2017 | 10.25% |
| Mar 31, 2017 | 10.57% |
| Dec 31, 2016 | 4.15% |
| Sep 30, 2016 | 5.34% |
| Jun 30, 2016 | 11.67% |
| Mar 31, 2016 | 19.39% |
| Dec 31, 2015 | 15.11% |
| Sep 30, 2015 | 8.56% |